Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma

BACKGROUND: The current TNM staging system for oesophageal adenocarcinoma (OAC) has limited ability to stratify patients and inform clinical management following neo-adjuvant chemotherapy and surgery. RESULTS: Functional genomic analysis of the gene expression data using Gene Set Enrichment Analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Blayney, Jaine K., Cairns, Lauren, Li, Gerald, McCabe, Niamh, Stevenson, Leanne, Peters, Christopher J., Reid, Nathan B., Spence, Veronica J., Chisambo, Chintapuza, McManus, Damian, James, Jacqueline, McQuaid, Stephen, Craig, Stephanie, Arthur, Kenneth, McArt, Darragh, Ong, Chin-Ann J., Lao-Sirieix, Pierre, Hamilton, Peter, Salto-Tellez, Manuel, Eatock, Martin, Coleman, Helen G., Fitzgerald, Rebecca C., Kennedy, Richard D., Turkington, Richard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915089/
https://www.ncbi.nlm.nih.gov/pubmed/29719622
http://dx.doi.org/10.18632/oncotarget.24906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915089/
https://www.ncbi.nlm.nih.gov/pubmed/29719622
http://dx.doi.org/10.18632/oncotarget.24906

Ejemplares similares